Latest stories on VRTX
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
The Motley Fool50 · neutralgeneral
Vertex Pharmaceuticals (VRTX) CEO Jeff Leiden's Leadership Journey
GuruFocus50 · neutralgeneral
The $500 Million Non-CF Factor Vertex Investors Can’t Ignore on Nov. 2
24/7 Wall St.63 · neutralearnings
Vertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change.
The Motley Fool63 · neutralproduct/pr
Vertex Pharmaceuticals Incorporated (VRTX) Presents at American Society of Nephrology (ASN) Kidney Week 2026 - Slideshow
Seeking Alpha52 · neutralproduct/pr
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
MarketWatch42 · neutralgeneral
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
Why Should You Think About Vertex Differently Now?
Yahoo Finance53 · neutralgeneral
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool50 · neutralgeneral
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
VERTEX PHARMACEUTICALS INC / MA (VRTX) files 8-K
SEC 8-K50 · neutralgeneral
Vertex Appoints Daniel Brennan to its Board of Directors
StockTitan53 · neutralgeneral
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
MarketWatch42 · neutralgeneral
Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts
Yahoo Finance56 · neutralgeneral
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch63 · neutralgeneral
Vertex to Announce Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Business Insider50 · neutralearnings
Vertex to Announce Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
GlobeNewswire50 · neutralearnings
Forget Cystic Fibrosis: Vertex's Next Growth Engine Could Be Hormone Disorders
The Motley Fool63 · neutralproduct/pr
What You Need to Know Ahead of Vertex Pharmaceuticals’ Earnings Release
Barchart56 · neutralearnings
Why is Vertex Pharmaceuticals stock sliding 4% today?
Investing.com Markets38 · neutralgeneral
Vertex price target lowered to $15 from $16 at TD Cowen
The Fly38 · neutralanalyst
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool64 · neutralanalyst
Vertex stock price target lowered to $15 by TD Cowen on valuation
Investing.com Analyst Ratings34 · bearishanalyst
BofA cuts Vertex stock price target to $667 on CF franchise outlook
Investing.com Analyst Ratings34 · bearishanalyst
Vertex Pharmaceuticals price target lowered to $667 from $672 at BofA
The Fly44 · neutralanalyst